Abbott Laboratories Net Revenue
Net Revenue of Abbott Laboratories 2005-2021
Amounts are in $millions.
| Year | Net Revenues ($mn) |
| 2021 | $43,675 |
| 2020 | $34,608 |
| 2019 | $31,904 |
| 2018 | $ 30,578 |
| 2017 | $ 27,390 |
| 2016 | $ 20,853 |
| 2015 | $ 20,405 |
| 2014 | $ 20,247 |
| 2013 | $19,657 |
| 2012 | $19,050 |
| 2011 | $18,663 |
| 2010 | $ 16,923 |
| 2009 | $ 16,551 |
| 2008 | $29,527.6 |
| 2007 | $ 25,914.2 |
| 2006 | $ 22,476.3 |
| 2005 | $ 22,337.8 |
Abbott Laboratories generated $43.87 billion in net revenues in 2021 compared to $34.6 billion in 2020.
The net revenues of Abbott Laboratories grew to $34.6 billion in 2020 compared to $31.9 billion in 2019.
Net Revenue of Abbott Laboratories grew to $30.6 billion in 2018 from $27.4 billion in 2017.
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Its main business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products.